(0.42%) 5 056.88 points
(0.84%) 38 133 points
(0.71%) 15 769 points
(-3.38%) $79.16
(-3.11%) $1.929
(1.27%) $2 332.20
(1.16%) $26.96
(1.48%) $962.20
(-0.26%) $0.935
(-0.41%) $11.05
(-0.13%) $0.799
(-0.48%) $93.00
Quarter results tomorrow
(bmo 2024-05-02)
Expected move: +/- 12.03%
0.00% $ 0.661
Live Chart Being Loaded With Signals
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe...
Stats | |
---|---|
Dzisiejszy wolumen | 321 668 |
Średni wolumen | 139 878 |
Kapitalizacja rynkowa | 821 028 |
EPS | $0 ( 2024-04-01 ) |
Następna data zysków | ( $0 ) 2024-05-02 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 0 |
ATR14 | $0.0120 (1.96%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-06-22 | Burns Thomas M. | Buy | 2 400 | Non-Employee Stock Option |
2023-06-22 | Burns Thomas M. | Buy | 0 | |
2023-06-22 | Varian John | Buy | 1 200 | Non-Employee Stock Option |
2023-06-22 | Panem Sandra Phd | Buy | 1 200 | Non-Employee Stock Option |
2023-06-22 | Kelley John P | Buy | 1 200 | Non-Employee Stock Option |
INSIDER POWER |
---|
99.33 |
Last 96 transactions |
Buy: 1 532 806 | Sell: 94 790 |
Wolumen Korelacja
Acorda Therapeutics Inc Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
HCTI | 0.95 |
TVTX | 0.945 |
ALBO | 0.939 |
MNST | 0.934 |
CMPI | 0.93 |
GNLN | 0.929 |
APLT | 0.929 |
MORF | 0.924 |
SBET | 0.922 |
UFO | 0.922 |
10 Najbardziej negatywne korelacje | |
---|---|
NTGR | -0.928 |
PI | -0.928 |
ATRS | -0.919 |
PPBT | -0.916 |
HONE | -0.912 |
CPSI | -0.912 |
BRAC | -0.908 |
KDNY | -0.907 |
MSAC | -0.903 |
LGTO | -0.901 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Acorda Therapeutics Inc Korelacja - Waluta/Towar
Acorda Therapeutics Inc Finanse
Annual | 2023 |
Przychody: | $117.63M |
Zysk brutto: | $71.59M (60.86 %) |
EPS: | $-203.59 |
FY | 2023 |
Przychody: | $117.63M |
Zysk brutto: | $71.59M (60.86 %) |
EPS: | $-203.59 |
FY | 2022 |
Przychody: | $118.57M |
Zysk brutto: | $88.23M (74.42 %) |
EPS: | $-66.90 |
FY | 2021 |
Przychody: | $129.07M |
Zysk brutto: | $88.28M (68.40 %) |
EPS: | $-12.86 |
Financial Reports:
No articles found.
Acorda Therapeutics Inc
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also markets Ampyra as Fampyra in Europe, Asia, and the Americas. In addition, the company develops ARCUS product for the treatment of acute migrain; rHIgM22, which has completed Phase I clinical trial for the treatment of MS; and Cimaglermin alfa for heart failure patients. The company has collaboration and license agreement with Biogen Inc. for the development and commercialization of Ampyra. Acorda Therapeutics, Inc. was incorporated in 1995 and is headquartered in Ardsley, New York.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej